Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Biostatistics (Oxford, England)
|
August 20, 2003
A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data
Finbarr O'Sullivan, Supratik Roy, Janet Eary
Cancer Biotherapy & Radiopharmaceuticals
|
January 25, 2005
Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma
Joseph Rajendran, Ajay Gopal, Lawrence Durack, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
November 19, 2003
Staging of head and neck squamous cell cancer with extended-field FDG-PET
David L Schwartz, Joseph Rajendran, Bevan Yueh, et al.
The American Journal of Pathology
|
May 31, 2008
The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake
Xiuyun Jiang, Heidi Kenerson, Lauri Aicher, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
December 22, 2004
FDG-PET prediction of head and neck squamous cell cancer outcomes
David L Schwartz, Joseph Rajendran, Bevan Yueh, et al.
Blood
|
May 6, 2003
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials
Sergio Giralt, William Bensinger, Mark Goodman, et al.
Head & Neck
|
February 14, 2006
Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression
Robert C Rostomily, Maria Elias, Mei Deng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 5, 2005
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma
David L Schwartz, Eric Ford, Joseph Rajendran, et al.
Head & Neck
|
March 18, 2005
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation
David L Schwartz, Eric C Ford, Joseph Rajendran, et al.
Oncotarget
|
February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesion
Stephanie A Harmon, Esther Mena, Joanna H Shih, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Biostatistics (Oxford, England)
|
August 20, 2003
A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data
Finbarr O'Sullivan, Supratik Roy, Janet Eary
Cancer Biotherapy & Radiopharmaceuticals
|
January 25, 2005
Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma
Joseph Rajendran, Ajay Gopal, Lawrence Durack, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
November 19, 2003
Staging of head and neck squamous cell cancer with extended-field FDG-PET
David L Schwartz, Joseph Rajendran, Bevan Yueh, et al.
The American Journal of Pathology
|
May 31, 2008
The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake
Xiuyun Jiang, Heidi Kenerson, Lauri Aicher, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
December 22, 2004
FDG-PET prediction of head and neck squamous cell cancer outcomes
David L Schwartz, Joseph Rajendran, Bevan Yueh, et al.
Blood
|
May 6, 2003
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials
Sergio Giralt, William Bensinger, Mark Goodman, et al.
Head & Neck
|
February 14, 2006
Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression
Robert C Rostomily, Maria Elias, Mei Deng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 5, 2005
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma
David L Schwartz, Eric Ford, Joseph Rajendran, et al.
Head & Neck
|
March 18, 2005
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation
David L Schwartz, Eric C Ford, Joseph Rajendran, et al.
Oncotarget
|
February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesion
Stephanie A Harmon, Esther Mena, Joanna H Shih, et al.
Page
of 2